Notably, patients with extrahepatic spread (EHS) showed a trend toward improved outcomes compared to those without, suggesting a possible differential response within certain subgroups.
← all excerpts
Reevaluating the Role of Demographic and Etiological Factors in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma.
1
—
—